The groundbreaking rise of Viagra has firmly established as a benchmark of pharmaceutical success, yet its position within the broader industry now triggers questions about long-term yields . Alternative versions are undercutting market share, prompting concerns that supporting companies closely tied to Viagra's previous standing could be a spec… Read More